Images of BEAS-2B cells and

HBEpCs exposed to MWNT-7 are shown in Fig. 3. MWNT-7 was observed near the nuclei and cytoplasm in BEAS-2B cells in Ham’s F12 and HBEpCs in SFGM. However, BEAS-2B cells in SFGM showed low internalization of MWNT-7, and some MWNT-7 adhered to the cell surface. We evaluated cytokine secretion by BEAS-2B cells incubated in Ham’s F12 and SFGM as well as HBEpCs incubated selleck chemicals in SFGM in response to MWNT-7. Although IL-6 secretion by untreated BEAS-2B cells in Ham’s F12 and untreated HBEpCs was sufficient for detection (33.8 ± 5.0 and 5.1 ± 0.5 pg/ml, respectively), secretion of IL-6 by BEAS-2B cells in SFGM was not detected (under 1.6 pg/ml). Exposure to MWNT-7 increased Talazoparib in vivo IL-6 secretion by BEAS-2B cells in Ham’s F12 and HBEpCs (Fig. 4a). However, the degree of the increase and the MWNT-7 concentration that stimulated the maximal increase were different: BEAS-2B cells in Ham’s F12 and HBEpCs showed a 20-fold and 2-fold upregulation in response to 10 μg/ml and 1 μg/ml MWNT-7, respectively. Moreover, IL-6 secretion in response to 50 μg/ml MWNT-7 was the same as that in response to 10 μg/ml MWNT-7 in BEAS-2B cells in Ham’s F12, but decreased to the level of the control in HBEpCs. IL-6 secretion by BEAS-2B cells in SFGM was lower than the detectable limit when the cells were exposed

to MWNT-7, even at the maximum concentration. IL-8 was secreted by both cell types under the untreated condition, and the concentration was on the order of HBEpC > BEAS-2B in SFGM > BEAS-2B in Ham’s F12 (814.1 ± 78.9, 260.2 ± 18.6 and 169.3 ± 22.0, respectively), (Fig. 4b). Upon exposure to 10 μg/ml MWNT-7, BEAS-2B cells in SFGM did not demonstrate a change in secretion, whereas other cell conditions produced increased IL-8 secretion. However, secretion in response to 50 μg/ml MWNT-7 did not

show a further increase. The increase was more pronounced in BEAS-2B cells in Ham’s F12 than in HBEpCs. Internalization of MWNT-7 by BEAS-2B cells in Ham’s F12 and HBEpCs in SFGM was suppressed by chlorpromazine, which is a clathrin-mediated endocytosis inhibitor, and indomethacin, which is a ID-8 caveolae-mediated endocytosis inhibitor. The cells showed extensive internalization of MWNT-7 for 2 h without the inhibitors, whereas cells pre-treated with the inhibitors showed little internalization of MWNT-7 and some MWNT-7 on the plasma membrane, as determined using fluorescence microscopy (Fig. 5a). The amount of internalized MWNT-7 was determined using the SSC relative ratio in BEAS-2B cells in Ham’s F12 and HBEpCs in SFGM treated with or without the inhibitors after exposure to MWNT-7 for 2 h, as shown in Fig. 5b and c. The SSC relative ratio for BEAS-2B cells that internalized MWNT-7 in SFGM is also shown in Fig. 5b. The amount of MWNTs internalized by BEAS-2B cells was significantly lower in SFGM medium than in F12 (Fig. 5b).